Issue Price
₹72
Per Share
GMP
NIL
Grey Market
Est. Listing
₹72
Expected Price
Min. Application
₹230,400
2 lots × 1600 shares
Vaishali Pharma Ltd. is proposing an Initial Public Offering (IPO) on the NSE SME platform under the SME category. The total issue size is 19,76,000 shares (aggregating up to ₹14.23 Cr).
Subscription opens 07 Aug 2017, closes 10 Aug 2017. Listing expected 22 Aug 2017. Apply via ASBA or UPI.
Vaishali Pharma Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Shares Offered | % Issue | Amount (₹ Cr)* | Subscription |
|---|---|---|---|---|
| Market Maker | 104,000 | — | ₹0.75 Cr | — |
| TOTAL | 1,976,000 | 100.00% | ₹14.23 Cr | — |
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,600 | ₹115,200 |
| Retail (Max) | 13 | 20,800 | ₹1,497,600 |
| sNII (Min) | 14 | 22,400 | ₹1,612,800 |
| bNII (Min) | 68 | 108,800 | ₹7,833,600 |
| Particulars | 31-Mar-17 | 31-Mar-16 | 31-Mar-15 |
|---|---|---|---|
| Revenue from Operations | 6711.22 | 6989.13 | 9882.37 |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | 66.37 | 3.03 | 16.15 |
| Net Worth | N/A | N/A | N/A |
| Total Assets | 4464.87 | 4941.31 | 4579.50 |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | N/A | N/A | N/A |